We are delighted to announce that Bryter is a winner at the British Healthcare Business Intelligence Association’s (BHBIA) 2023 BOBI Awards.
The award comes in the 'Best Business Impact' category
This is the eighth time the healthcare team has been shortlisted for a BOBI award in the last six years, and reflects Bryter's ongoing commitment to delivering research that makes a difference to our clients' businesses.
Summary of submission: From PoM to P: The insight-driven development of Britain’s first over-the-counter local vaginal hormone replacement therapy.
1. A comprehensive research program in support of the successful reclassification and launch of the first ever local vaginal HRT to become available over-the-counter in the UK.
2. Insight from quantitative data analysis and focus groups with patients and pharmacists were integral parts of an ultimately successful product launch.
3. The research carried out gave vital input into commercial preparations for the launch of a key product to support the health and wellbeing of women requiring HRT
These real-life, panel-judged awards require us to show clear guidance, evidence of change, customer understanding and impact to the client’s business as a result of the research.
The British Healthcare Business Intelligence Association (BHBIA, www.bhbia.org.uk) is the pre-eminent association for the UK’s healthcare and pharmaceutical market researchers.
The BOBI (Best of Business Intelligence) Awards are the only healthcare-specific business intelligence awards scheme in the UK, and recognize excellence across the business intelligence spectrum – from market research through to sales analytics and related disciplines. The full awards shortlist can be found here: https://www.bhbia.org.uk/bobi-awards
The Awards Ceremony takes place at the BHBIA Annual Conference in May each year.
Get in touch if you would like to receive case studies demonstrating how we deliver business impact for clients across the globe!